- |||||||||| Covaxin (BBV152 COVID Vaccine) / Bharat Biotech, Indian Council of Medical Research, Ocugen, Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: Delta variant spreading worldwide at scorching pace : #TedrosAdhanomGhebreyesus @DrTedros @doctorsoumya @WHO @_AnabelG #WorldHealthOrganization #WHO #DeltaPlusCovidvariant #Covid19 #Coronavirus #Covidvax #COVAXIN #COVISHIELD #AstraZeneca #SputnikV https://t.co/5F64w5qWTN (Twitter) - Jul 13, 2021
- |||||||||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Sputnik V (Twitter) - Jul 9, 2021
- |||||||||| Covaxin (BBV152 COVID Vaccine) / Bharat Biotech, Indian Council of Medical Research, Ocugen, Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: There are many types of vaccines available in India 🇮🇳 that you can get, Covishield 🇬🇧 Covaxin 🇮🇳 Sputnik-V 🇷🇺 Moderna 🇺🇸 Upcoming Zydus Cadila 🇮🇳 Novowax 🇺🇸 Corbevax 🇮🇳 Pfizer 🇺🇸 Gennova biopharmaceutical (mRNA) 🇮🇳 (Twitter) - Jul 8, 2021
- |||||||||| MT2766 / Mitsubishi Tanabe, Laval University, Dynavax, GSK, Covaxin (BBV152 COVID Vaccine) / Bharat Biotech, Indian Council of Medical Research, Ocugen, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: Comparing vaccines: country of origin, safety, doses, price, efficacy, and approval. Pfizer, Johnson & Johnson, Moderna, AstraZeneca, Sputnik V, Sinopharm, Bharat Biotech (COVAXIN), Medicago (CoVLP) the reasons why you shouldn't worry about vaccines https://t.co/JAqesi7Prv (Twitter) - Jul 4, 2021
- |||||||||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
@EMA_News and sputnikv? (Twitter) - Jul 4, 2021
- |||||||||| Covaxin (BBV152 COVID Vaccine) / Bharat Biotech, Indian Council of Medical Research, Ocugen, Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: These results give all of us a lot of reassurance that Covaxin is an excellent option to prevent COVID in India. No one should hesitate to get whichever vaccine is offered to them in India. They are all good: Covaxin, Covishield, Sputnik V, or Pfizer (if available). (Twitter) - Jul 2, 2021
- |||||||||| Covaxin (BBV152 COVID Vaccine) / Bharat Biotech, Indian Council of Medical Research, Ocugen, Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: 2/ Women can be vaccinated at any stage in pregnancy Any of the 3 vaccines available in India can be used - Covishield, Covaxin or Sputnik V (Twitter) - Jul 2, 2021
- |||||||||| Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford
Trial completion date, Trial initiation date, Trial primary completion date: Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 (clinicaltrials.gov) - Jul 2, 2021 P1/2, N=100, Not yet recruiting, Trial completion date: Oct 2021 --> Apr 2022 | Initiation date: Mar 2021 --> Aug 2021 | Trial primary completion date: Oct 2021 --> Apr 2022
- |||||||||| Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Journal: Adenovirus and RNA-based COVID-19 vaccines' perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey. (Pubmed Central) - Jun 30, 2021 Awareness by HCWs of the several COVID-19 candidate vaccines could improve their perceptions and acceptance of vaccination. Reliable sources on vaccine efficiency could improve vaccine uptake, so healthcare authorities should use reliable information to decrease vaccine hesitancy among frontline healthcare providers.
|